[123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Delta9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patients (abst – 2004)http://www.ncbi.nlm.nih.gov/pubmed/15110734
Effects of AM281, a cannabinoid antagonist, on systemic haemodynamics, internal carotid artery blood flow and mortality in septic shock in rats (full – 2005) http://bja.oxfordjournals.org/content/94/5/563.full
Treatment of Tourette-syndrome with cannabinoids: results from clinical and neuroimaging studies (abst – 2005) https://www.thieme-connect.com/ejour.../s-2005-918789
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors (abst – 2005)http://www.sciencedirect.com/science...14299905013178
Effects of AM281, a cannabinoid antagonist, on circulatory deterioration and cytokine production in an endotoxin shock model: comparison with norepinephrine (abst – 2006) http://www.ncbi.nlm.nih.gov/pubmed/17072693
The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation (full – 2009)http://www.fasebj.org/content/23/1/183.long
GPR55 ligands promote receptor coupling to multiple signalling pathways (full – 2010)http://www.ncbi.nlm.nih.gov/pmc/arti...1/?tool=pubmed
Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype (full – 2010)http://ajpgi.physiology.org/content/...b-afaa05ee417c
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/arti...8/?tool=pubmed
Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells (full – 2012)http://www.spandidos-publications.co...?text=fulltext
Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors (full – 2012) http://www.jbc.org/content/early/201....full.pdf+html
Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496738/
The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55 (full – 2012)http://www.jbc.org/content/early/201...12.364109.long
Regulation of endocannabinoid release by G proteins: A paracrine mechanism of G protein-coupled receptor action (abst – 2012)http://www.ncbi.nlm.nih.gov/pubmed/22075205
Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22959964
Endogenous cannabinoid receptor CB1 activation promotes vascular smooth muscle cell proliferation and neointima formation (full – 2013)http://www.jlr.org/content/early/201...r.M035147.long
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice (full – 2013)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808422/
Acetaldehyde as a drug of abuse: insight into AM281 administration on operant-conflict paradigm in rats (full – 2013)http://www.frontiersin.org/Behaviora...013.00064/full
AM281, Cannabinoid Antagonist/Inverse agonist, Ameliorates Scopolamine-Induced Cognitive Deficit (full – 2013)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586915/
Cannabinoid receptor activation in the nucleus tractus solitaries produces baroreflex-like responses in the rat (full – 2013)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614708/
GPR55 and its interaction with membrane lipids: comparison with other endocannabinoid-binding receptors (link to PDF - 2013)http://www.eurekaselect.com/105678/article
Cannabinoid Receptors as Therapeutic Targets for Dialysis-Induced Peritoneal Fibrosis (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23296044
The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer pain (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23673278
Dysregulation of Cannabinoid CB1 Receptor and Associated Signaling Networks in Brains of Cocaine Addicts and Cocaine-Treated Rodents (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23727505
Peripheral and Spinal Activation of Cannabinoid Receptors by Joint Mobilization Alleviates Postoperative Pain in Mice (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24120553
The effect of AM281, a cannabinoid antagonist, on memory performance during spontaneous morphine withdrawal in mice (full – 2014)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895301/
2012 Division of Medicinal Chemistry Award Address: Trekking the Cannabinoid Road: A Personal Perspective (full– 2014)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064474/
Effects of cannabinoids on tension induced by acetylcholine and choline in slow skeletal muscle fibers of the frog (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24218022
Effects of AM281, a cannabinoid antagonist, on systemic haemodynamics, internal carotid artery blood flow and mortality in septic shock in rats (full – 2005) http://bja.oxfordjournals.org/content/94/5/563.full
Treatment of Tourette-syndrome with cannabinoids: results from clinical and neuroimaging studies (abst – 2005) https://www.thieme-connect.com/ejour.../s-2005-918789
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors (abst – 2005)http://www.sciencedirect.com/science...14299905013178
Effects of AM281, a cannabinoid antagonist, on circulatory deterioration and cytokine production in an endotoxin shock model: comparison with norepinephrine (abst – 2006) http://www.ncbi.nlm.nih.gov/pubmed/17072693
The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation (full – 2009)http://www.fasebj.org/content/23/1/183.long
GPR55 ligands promote receptor coupling to multiple signalling pathways (full – 2010)http://www.ncbi.nlm.nih.gov/pmc/arti...1/?tool=pubmed
Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype (full – 2010)http://ajpgi.physiology.org/content/...b-afaa05ee417c
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/arti...8/?tool=pubmed
Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells (full – 2012)http://www.spandidos-publications.co...?text=fulltext
Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors (full – 2012) http://www.jbc.org/content/early/201....full.pdf+html
Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496738/
The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55 (full – 2012)http://www.jbc.org/content/early/201...12.364109.long
Regulation of endocannabinoid release by G proteins: A paracrine mechanism of G protein-coupled receptor action (abst – 2012)http://www.ncbi.nlm.nih.gov/pubmed/22075205
Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22959964
Endogenous cannabinoid receptor CB1 activation promotes vascular smooth muscle cell proliferation and neointima formation (full – 2013)http://www.jlr.org/content/early/201...r.M035147.long
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice (full – 2013)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808422/
Acetaldehyde as a drug of abuse: insight into AM281 administration on operant-conflict paradigm in rats (full – 2013)http://www.frontiersin.org/Behaviora...013.00064/full
AM281, Cannabinoid Antagonist/Inverse agonist, Ameliorates Scopolamine-Induced Cognitive Deficit (full – 2013)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586915/
Cannabinoid receptor activation in the nucleus tractus solitaries produces baroreflex-like responses in the rat (full – 2013)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614708/
GPR55 and its interaction with membrane lipids: comparison with other endocannabinoid-binding receptors (link to PDF - 2013)http://www.eurekaselect.com/105678/article
Cannabinoid Receptors as Therapeutic Targets for Dialysis-Induced Peritoneal Fibrosis (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23296044
The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer pain (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23673278
Dysregulation of Cannabinoid CB1 Receptor and Associated Signaling Networks in Brains of Cocaine Addicts and Cocaine-Treated Rodents (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23727505
Peripheral and Spinal Activation of Cannabinoid Receptors by Joint Mobilization Alleviates Postoperative Pain in Mice (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24120553
The effect of AM281, a cannabinoid antagonist, on memory performance during spontaneous morphine withdrawal in mice (full – 2014)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895301/
2012 Division of Medicinal Chemistry Award Address: Trekking the Cannabinoid Road: A Personal Perspective (full– 2014)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064474/
Effects of cannabinoids on tension induced by acetylcholine and choline in slow skeletal muscle fibers of the frog (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/24218022